Ascendis Pharma A/S (ASND)
205.70
-4.75
(-2.26%)
USD |
NASDAQ |
Jun 08, 16:00
205.82
+0.12
(+0.06%)
After-Hours: 20:00
Ascendis Pharma Price : 205.70 for June 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Evaxion AS | 3.74 |
| DBV Technologies SA | 16.05 |
| Genmab A/S | 24.80 |
| Cellectis SA | 2.94 |
| Akari Therapeutics Plc | 15.68 |
Price Related Metrics
| PE Ratio | 23.18 |
| PS Ratio | 12.64 |
| Price to Book Value | 22.72 |
| Price to Free Cash Flow | 251.30 |
| Earnings Yield | 4.31% |
| Market Cap | 12.78B |
| Normalized PE Ratio | 23.18 |